Quantity size:
0.2ml
Concentration:
1mg/ml TATA盒结合蛋白相关因子TAF1C抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Initiation of transcription by RNA polymerase I requires the formation of a complex composed of the TATA-binding protein (TBP) and three TBP-associated factors (TAFs) specific for RNA polymerase I. This complex, known as SL1, binds to the core promoter of ribosomal RNA genes to position TATA盒结合蛋白相关因子TAF1C抗体the polymerase properly and acts as a channel for regulatory signals. This gene encodes the largest SL1-specific TAF. Multiple alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2011]
TATA盒结合蛋白相关因子TAF1C抗体Also known as:
RNA polymerase I-specific TBP-associated factor 110 kDa; SL1; Taf1c; TAF1C_HUMAN; TAFI110; TAFI95; TATA box binding protein associated factor 1C; TATA box-binding protein-associated factor 1C; TATA box-binding protein-associated factor RNA polymerase I subunit C; TBP associated factor 1C; TBP associated factor RNA polymerase I 95 kDa; TATA盒结合蛋白相关因子TAF1C抗体TBP associated factor, RNA polymerase I, 110-KD; TBP-associated factor 1C; Transcription initiation factor SL1/TIF-IB subunit C.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated synthetic peptide derived from human TAF1C.
●
TATA盒结合蛋白相关因子TAF1C抗体Predicted Molecular Weight: 95kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user
kl769Mu01肝脂酶(LIPC)多克隆抗体Polyclonal Antibody to Likle, Heklic (LIPC)
kl769Ra01肝脂酶(LIPC)多克隆抗体Polyclonal Antibody to Likle, Heklic (LIPC)
kl769Po01肝脂酶(LIPC)多克隆抗体Polyclonal Antibody to Likle, Heklic (LIPC)
kl226Hu01胃脂酶(LIPF)多克隆抗体Polyclonal Antibody to Likle, Gastric (LIPF)
kl226Mu01胃脂酶(LIPF)多克隆抗体Polyclonal Antibody to Likle, Gastric (LIPF)
kl226Ra01胃脂酶(LIPF)多克隆抗体Polyclonal Antibody to Likle, Gastric (LIPF)
kl226Po01胃脂酶(LIPF)多克隆抗体Polyclonal Antibody to Likle, Gastric (LIPF)
kl469Hu01内皮脂肪酶(LIPG)多克隆抗体Polyclonal Antibody to Likle, Endothelial (LIPG)
kl469Mu01内皮脂肪酶(LIPG)多克隆抗体Polyclonal Antibody to Likle, Endothelial (LIPG)
kl469Ra01内皮脂肪酶(LIPG)多克隆抗体Polyclonal Antibody to Likle, Endothelial (LIPG)
kl176Hu01脂肪酶I(LIPI)多克隆抗体Polyclonal Antibody to Likle I (LIPI)
kl176Mu01脂肪酶I(LIPI)多克隆抗体Polyclonal Antibody to Likle I (LIPI)
kl176Ra01脂肪酶I(LIPI)多克隆抗体Polyclonal Antibody to Likle I (LIPI)
kl175Hu01脂肪酶H(LIPH)多克隆抗体Polyclonal Antibody to Likle H (LIPH)
kl175Mu01脂肪酶H(LIPH)多克隆抗体Polyclonal Antibody to Likle H (LIPH)
kl386Hu01脂蛋白脂酶(LIPD)多克隆抗体Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl386Mu01脂蛋白脂酶(LIPD)多克隆抗体Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl386Ra01脂蛋白脂酶(LIPD)多克隆抗体Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl225Hu01溶酶体酸脂肪酶A(LIPA)多克隆抗体Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl225Mu01溶酶体酸脂肪酶A(LIPA)多克隆抗体Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl225Ra01溶酶体酸脂肪酶A(LIPA)多克隆抗体Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl526Ge01脂多糖(LPS)多克隆抗体Polyclonal Antibody to Lipopolysaccharide (LPS)
kl082Hu01层粘连蛋白γ1(LAMγ1)多克隆抗体Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl082Mu01层粘连蛋白γ1(LAMγ1)多克隆抗体Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl082Ra01层粘连蛋白γ1(LAMγ1)多克隆抗体Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl014Hu01骨成型蛋白4(BMP4)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话